Price Registration for Future Medicines Acquisition - Group 5. Protocol No. 22.246.662-8 Tender

Procurement Summary

Country : Brazil

Summary : Price Registration for Future Medicines Acquisition - Group 5. Protocol No. 22.246.662-8

Deadline : 18 Jul 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 122248006

Document Ref. No. : 90807/2025

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Object: Electronic Auction - Price Record for Future Medicines Acquisition - Group 5. Protocol No. 22.246.662-8

UASG Code: 456793

Notice from: 07/07/2025 from 08:00 to 12:00 and from 13:00 to 17:59 hs

Proposal Delivery: From 07/07/2025 to 08:00

Polymyxin B, composition Associated with neomycin and dexamethasone, concentration 6.000UI + 0.5% + 0.1%, ophthalmic use

Quantity: 180

Glycerol, dosage 95%, children's supposition

Quantity: 108

Glucose, 25%concentration, indication injectable solution

Quantity: 25540

Sodium bicarbonate, presentation DUST

Quantity: 180

Moxifloxacin, dosage 1.6 mg/ml, pharmaceutical form injectable solution

Quantity: 1000

Ofloxacino, 3 mg/ml dosage, ophthalmic solution

Quantity: 108

Ampicillin, composition associated with sulbactam, concentration 2 g + 1 g, pharmaceutical form powder for injectable solution

Amount : 31040

Ethanolamine oleato, 5%concentration, use injectable solution

Quantity: 108

Beclomethasone Dipropionate, concentration 50 mcg/ dose, pharmaceutical form aerosol oral, additional characteristic dose vial w/ aircraft nozzle

Quantity: 2878

Nicotine, concentration release of 21 mg in 24 hours, transdermal adhesive pharmaceutical form

Quantity: 2140

Anidulafungina, 100 mg concentration, pharmaceutical form lipyl powder for injectable

Quantity: 816

DROPERIDOL, concentration 2.50 mg/ml, indication injectable solution

Quantity: 133

Calcical Ethylenodiaminotetracetracetracetic, Concentration 200 Mg/ml, pharmaceutical form injectable solution, additional characteristic specially manipulated

Quantity: 216

Documents

 Tender Notice